Gilead Sciences' remdesivir shows improvement in coronavirus patients with moderate pneumonia
Patients taking a 5-day course of treatment recover faster compared to the standard of care
Company
Gilead Sciences Inc
NASDAQ:GILD
Gilead Sciences Inc is a biopharmaceutical company. The company is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. Gilead Sciences Inc offers products in HIV, Onocolgy, Liver Disease, Vekulaery and Other.
86 stories · page 2 of 5
Gilead Sciences, Roche to study remdesivir/Actemra combination in coronavirus patients
Gilead’s remdesivir is currently approved as emergency treatment for coronavirus while Roche has been studying the effectiveness of arthritis treatment Actemra
Gilead Sciences' remdesivir to be available for selected coronavirus patients in the UK
The drug is being used as emergency treatment in Japan and the US, while generic versions will be distributed in 127 countries
Gilead Sciences' remdesivir to be distributed in 127 countries
The deals were signed with Cipla, Ferozsons Laboratories, Hetero Labs, Jubilant Lifesciences and Mylan
Gilead Sciences' remdesivir receives US emergency approval for coronavirus treatment
The temporary authorisation follows trials that confirmed the drug allows for faster recovery but safety and efficacy have not been proven yet
Gilead Sciences' remdesivir could get US emergency approval for coronavirus treatment
The drug has not been approved anywhere yet and has not been demonstrated to be safe or effective in coronavirus cases.
Gilead Sciences posts positive data on coronavirus treatment trial
Patients receiving a ten-day course of remdesivir achieved similar improvement compared with those being treated for five days
Gilead Sciences says studies for coronavirus treatment still inconclusive after unsuccessful trial in China
The World Health Organization accidentally posted data from trials in China showing that the drug, considered very promising, was not successful
Hardware & electrical equipment
Coronavirus research: who got the priority label from the government
Here are some of the companies involved in projects that have been fast-tracked by the UK authorities
Coronavirus: What’s happening in the labs of pharma companies worldwide
A list of the major pharma players looking for solutions to tackle the pandemic
Gilead Sciences gives hope for coronavirus treatment with latest data
Remdesivir was originally designated as a treatment for Ebola
S&P/ASX 200 futures down 1.2% heading into the open, US markets fall overnight
The S&P 500 closed down 2.93% and the Nasdaq Composite closed down 0.27%.
Gilead gets a boost as its Ebola drug gets repurposed to treat the coronavirus
It is working with Chinese officials to set up a study of the drug’s effectiveness against the virus
Pharma stocks head south as Trump forces them to display drug prices in TV ads
“Drug companies have to come clean about their prices in TV ads. If drug companies are ashamed of those prices – lower them!”
Viking Therapeutics shares pop after rival Gilead's liver drug trial falls short
Viking stands to benefit after Gilead’s drug selonsertib did not meet its primary endpoint in a Phase 3 trial
Late Movers: Walt Disney rallies after reporting 1Q results that beat estimates
Also moving were Electronic Arts and General Motors, which reports Wednesday
Small-Cap Snapshot: Pier 1 Imports slumps after saying it's exploring strategic options
MannKind, Agenus and BlackBerry are also seeing trading action
Agenus partners with Gilead Sciences to develop five immuno-oncology therapies
Agenus will receive a $120 million upfront payment and a $30 million equity investment from Gilead
Archive
Proactive news snapshot: Sirius Minerals, MaxCyte, Arix Bioscience...
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Two Shields and Bushveld wave the flag for African mineral assets
A look at the day's winners and sinners, including Dignity, Online Blockchain, Restaurant Group, TomCo Energy, Johnston Press, GYG, Anglo African Agriculture and Carr's Group